Filing Details

Accession Number:
0001209191-19-021208
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-25 17:51:18
Reporting Period:
2019-03-25
Accepted Time:
2019-03-25 17:51:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
831547 Spectrum Pharmaceuticals Inc SPPI Pharmaceutical Preparations (2834) 930979187
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1462354 A Kurt Gustafson 11500 S. Eastern Ave.
Suite 240
Henderson NV 89052
Evp & Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Disposition 2019-03-25 3,797 $9.46 247,640 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.001 7,507 Indirect By 401(k) Plan
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
  2. Since the date of the reporting person's last ownership report, he transferred 5,459 shares of the Company's common stock to his ex-wife pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-wife.